Comparison of age at diagnosis, Gleason Score and PSA at diagnosis between carriers of the truncating <i>TP53AIP1</i> variants and non-carriers.

a<p>: heterozygous.</p>b<p>: probands with available information for specified parameter.</p

Genotype specific odds ratio (OR), exact 95% confidence interval (CI 95%) and p-values of truncating <i>TP53AIP1</i> variants in case control comparisons.

a<p>: heterozygous.</p>b<p>: including 377 familial and 325 sporadic prostate cancer patients.</p